| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/19/2006 | WO2006014618A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 10/19/2006 | WO2006002106A3 Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
| 10/19/2006 | WO2005118610A3 Macrocyclic compounds and methods of making and using the same |
| 10/19/2006 | WO2005105040A3 Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/19/2006 | WO2005102367A3 Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer |
| 10/19/2006 | WO2005102324A3 STABLE, NEUTRAL pH, VOC-FREE BIOCIDAL COMPOSITIONS OF 1,2-BENZISOTHIAZOLIN-3-ONE |
| 10/19/2006 | WO2005092058A3 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses |
| 10/19/2006 | WO2005091960A3 Method for inhibiting fibrocartilage degradation |
| 10/19/2006 | WO2005070072A3 Reciprocal regulation of inflammation and lipid metabolism by liver x receptors |
| 10/19/2006 | WO2005069916A3 Topical co-enzyme q10 formulations and methods of use |
| 10/19/2006 | WO2005068632A8 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME |
| 10/19/2006 | WO2005042101A8 Composition and dosage form for sustained effect of levodopa |
| 10/19/2006 | WO2005034860A3 Thiol reactive agents as a therapeutic modality |
| 10/19/2006 | WO2005023182A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 10/19/2006 | WO2005014542A3 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament against cancer, and method for the production thereof |
| 10/19/2006 | US20060235521 Spinous process implant with tethers |
| 10/19/2006 | US20060235503 Local drug delivery devices and methods for maintaining the drug coatings thereon |
| 10/19/2006 | US20060235351 External preparation, method of applying external preparation, iontophoresis device, and percutaneous patch |
| 10/19/2006 | US20060235239 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 10/19/2006 | US20060235223 Variolin derivatives and their use as antitumor agents |
| 10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
| 10/19/2006 | US20060235132 Method of preparing poly(vinyl pivalate) by low temperature suspension-polymerization of vinyl pivalate, and poly(vinyl pivalate) and poly(vinyl alcohol) prepared using same |
| 10/19/2006 | US20060235082 Long-chain, straight-chain 2-amino-3-hydroxyalkanes |
| 10/19/2006 | US20060235081 1-(2-hydroxyphenyl)-2,6-dione-3-ene-4-hydroxy-heptane; suppressing excess immunoglobulin (IgE) levels, eliminating side effects associated with tetracyclines; asthma, allergies, inflammatory conditions, or other diseases where IgE is pathogenic |
| 10/19/2006 | US20060235080 Topically active agents to remove actinic keratoses and basal (BCC) and squamous (SCC) cell carcinomas using a combination of sulindac, its metabolites and derivatives with an oxidizing agent to generate reactive oxygen species nontoxic to normal cells; sulindac methionine sulfoxide/hydrogen peroxide |
| 10/19/2006 | US20060235079 Process for the preparation of gabapentin form-II |
| 10/19/2006 | US20060235078 Use of triterpenes of given formula based on a picene ring structure; side effect reduction such as of insulin resistance over current antidiabetes agents |
| 10/19/2006 | US20060235077 Diverticular remodling technique |
| 10/19/2006 | US20060235076 Medicinal composition for treating infection with drug-resistant staphylococcus aureus |
| 10/19/2006 | US20060235074 Matrix metalloproteinase inhibitors |
| 10/19/2006 | US20060235073 Diamino-functional chalcones |
| 10/19/2006 | US20060235072 Potassium channel opener |
| 10/19/2006 | US20060235070 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases |
| 10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
| 10/19/2006 | US20060235068 Ophthalmological surgery colorant and delivery system |
| 10/19/2006 | US20060235067 Such as: {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone relataed prostate cancer and pre-menopausal breast cancer |
| 10/19/2006 | US20060235065 e.g 3-(7,7-Dimethyl-6-oxo-1,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl)-1H-pyrazol-4-yl]-carbamic acid benzyl ester; Aurora A (serotonin/threonine) kinase inhibitors; anticarcinogenic agent; colorectal, breast, lung, prostate, pancreatic, gastric, bladder, ovarian cancer, melanoma, neuroblastoma |
| 10/19/2006 | US20060235062 Novel heterocyclic analogs of diphenylethylene compounds |
| 10/19/2006 | US20060235061 Methods of using benzothiophenone derivatives to treat cancer or inflammation |
| 10/19/2006 | US20060235060 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 10/19/2006 | US20060235059 administering two or more timed doses of 7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[1-methyl-2-(2-methylsulfanyl-thiazol-4-yl)-vinyl]-4,17-dioxa-bicyclo[14.1.0]heptadecane-5,9-dione also called epothilone b; treating a drug resistant tumor |
| 10/19/2006 | US20060235058 Substituted 5-membered ring compounds and their use |
| 10/19/2006 | US20060235057 Phenyl compounds |
| 10/19/2006 | US20060235056 Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives |
| 10/19/2006 | US20060235055 Therapeutic agents useful for treating pain |
| 10/19/2006 | US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent |
| 10/19/2006 | US20060235053 Agents for the treatment of lower abdominal disorders |
| 10/19/2006 | US20060235052 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses |
| 10/19/2006 | US20060235051 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide; viricide; with other active agents: interferons, ribavirin, immunoglobulins, immunomodulators, anti-inflammatory agents, antibiotics, antivirals or anti-infectious |
| 10/19/2006 | US20060235050 Diamine calcium channel blockers |
| 10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |
| 10/19/2006 | US20060235048 Treatment of connective tissue diseases of the skin |
| 10/19/2006 | US20060235047 Antibacterial compounds and uses thereof |
| 10/19/2006 | US20060235046 Use of an epidermal growth factor receptor kinase inhibitor (EGFR) in gefitinib resistant patients |
| 10/19/2006 | US20060235045 Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 10/19/2006 | US20060235044 Azabicyclononene derivatives |
| 10/19/2006 | US20060235043 Antiviral Pyrazolopyridine Compounds |
| 10/19/2006 | US20060235042 Substitued azaindoline intermediate for use in the manufacture of 5-substituted 7-azaindolines and 5-substituted 7-azaindoles; pharmaceutical intermediates |
| 10/19/2006 | US20060235041 New isothiazoloquinolones and related compounds as anti-infective agents |
| 10/19/2006 | US20060235040 Pharmaceutical compositions containing camptothecins |
| 10/19/2006 | US20060235039 Hydromorphone polymorphs |
| 10/19/2006 | US20060235038 Novel therapeutic uses for nalmefene |
| 10/19/2006 | US20060235037 Heterocyclic inhibitors of protein arginine methyl transferases |
| 10/19/2006 | US20060235036 Vanilloid receptor ligands and their use in treatments |
| 10/19/2006 | US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders |
| 10/19/2006 | US20060235034 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 10/19/2006 | US20060235033 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
| 10/19/2006 | US20060235032 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 10/19/2006 | US20060235031 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 10/19/2006 | US20060235030 Novel compounds |
| 10/19/2006 | US20060235029 Novel compounds |
| 10/19/2006 | US20060235028 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
| 10/19/2006 | US20060235027 Inhibitors of cdc25 phosphatases |
| 10/19/2006 | US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists |
| 10/19/2006 | US20060235025 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 10/19/2006 | US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
| 10/19/2006 | US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same |
| 10/19/2006 | US20060235022 Therapeutic agents useful for treating pain |
| 10/19/2006 | US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors |
| 10/19/2006 | US20060235020 Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein |
| 10/19/2006 | US20060235019 Substituted quinazolinone compounds |
| 10/19/2006 | US20060235018 Prokineticin 1 receptor antagonists |
| 10/19/2006 | US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma |
| 10/19/2006 | US20060235016 Morpholine Dopamine Agonists |
| 10/19/2006 | US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators |
| 10/19/2006 | US20060235014 Inhibitors of p38 |
| 10/19/2006 | US20060235013 Tricyclic azole derivatives |
| 10/19/2006 | US20060235012 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 10/19/2006 | US20060235011 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine; depressive symptom, mania, anxiety, general anxiety disorder, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, Tourette's syndrome |
| 10/19/2006 | US20060235010 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives |
| 10/19/2006 | US20060235009 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors |
| 10/19/2006 | US20060235008 Novel polymorphs of efavirenz |
| 10/19/2006 | US20060235007 Substituted 1,4-diazepines and uses thereof |
| 10/19/2006 | US20060235006 Combinations, methods and compositions for treating cancer |
| 10/19/2006 | US20060235005 Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia |
| 10/19/2006 | US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 10/19/2006 | US20060235003 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 10/19/2006 | US20060235002 Novel physiologically active substance |
| 10/19/2006 | US20060235001 Compositions for the treatment of neoplasms |